Gilead Sciences, Inc. (GILD) Free Cash Flow
Gilead Sciences, Inc. (GILD) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $16.30B |
| 2017-12-31 | $11.31B |
| 2018-12-31 | $7.48B |
| 2019-12-31 | $8.32B |
| 2020-12-31 | $7.52B |
| 2021-12-31 | $10.80B |
| 2022-12-31 | $8.34B |
| 2023-12-31 | $7.42B |
| 2024-12-31 | $10.30B |
| 2025-12-31 | $9.46B |
How GILD compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| MRK | Merck & Company Inc. | $12.36B |
| PFE | Pfizer Inc. | $9.07B |
| AMGN | Amgen Inc. | $8.10B |
| CVS | CVS Health Corporation | $7.81B |
| ABT | Abbott Laboratories | $7.39B |
These are five companies in the same sector as GILD with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Gilead Sciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("GILD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GILD | $151.00 | -0.15% | 6.17M |
| 3 | ||||
| 4 | ||||
| 5 |